| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.085 | 0.5 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |